Eden Medical
Private Company
Funding information not available
Overview
Eden Medical is a private, pre-revenue medical technology company founded in 2019 and headquartered in South Haven, Minnesota. The company is developing a platform of non-invasive diagnostic and monitoring devices, primarily for diabetic foot wound care, to address the limitations of subjective, surface-only visual assessment. Led by founder and CEO Jeff Schoess, an experienced medical device inventor with significant NIH grant funding, the company is seeking partnerships and licensing agreements to commercialize its patented technologies. Its core value proposition is reducing the massive economic burden and poor clinical outcomes associated with chronic diabetic wounds.
Technology Platform
Platform of non-invasive sensing and imaging technologies, including near-infrared spectral imaging, smart moisture/exudate mapping, and sensor-integrated wearables, for objective assessment and monitoring of wound and peristomal skin conditions.
Opportunities
Risk Factors
Competitive Landscape
Eden Medical competes in the advanced wound diagnostics space against other imaging technologies (e.g., hyperspectral imaging from companies like HyperMed Imaging, now part of Nitto Denko) and digital wound measurement apps. Its integrated approach combining prevention, imaging, and smart wearables for both wounds and ostomy care is a differentiating factor, but it faces competition from large, established wound care companies (e.g., Smith & Nephew, 3M, Mölnlycke) with extensive commercial reach.